Hjem › Hjernetumorer › Illinois
Hjernetumorer kliniske forsøg i Illinois
14 studier for Hjernetumorer søger deltagere på steder i Illinois.
Byer i Illinois
Officiel studietekst (engelsk)
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- Saint Anthony's Health, Alton
- Rush - Copley Medical Center, Aurora
- Illinois CancerCare-Bloomington, Bloomington
- og 33 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT04511013Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- University of Chicago, Chicago
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT02747303A Phase 1/1b Study of IAM1363 in HER2 Cancers
- University of Chicago, Chicago
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06253871Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Carle Cancer Center, Urbana
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT05386108Targeted Pediatric High-Grade Glioma Therapy
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RekruttererObservationsstudie
12 Months – 39 Years · Alle køn · Opdateret 8. sep. 2026 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RekruttererFase 2
Alder 12 til 39 · Alle køn · Opdateret 1. sep. 2026 · NCT06161974A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
- Robert H. Lurie Comprehensive Cancer Center Northwestern University, Chicago
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 21. aug. 2026 · NCT06764940Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
- Lurie Children's Hospital, Chicago
RekruttererFase 2
Alder 1 til 26 · Alle køn · Opdateret 4. aug. 2026 · NCT07680439REMASTer: REcurrent Brain Metastases After SRS Trial
- University of Chicago, Chicago
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 18. jun. 2026 · NCT05124912Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- Decatur Memorial Hospital, Decatur
- HSHS Saint Elizabeth's Hospital, O'Fallon
- Methodist Medical Center of Illinois, Peoria
- og 2 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. jun. 2026 · NCT03550391Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RekruttererFase 2
12 Months – 39 Years · Alle køn · Opdateret 29. maj 2026 · NCT05843253Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Northwestern Memorial Hospital, Chicago
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 13. apr. 2026 · NCT06810544Intraoperative Fluorescence-Guided Aspirate Tissue Monitoring of 5-ALA During Brain Tumor Surgery
- University of Illinois at Chicago, Chicago
Rekrutterer
Alder 18 til 99 · Alle køn · Opdateret 12. nov. 2025 · NCT07111182S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- John H Stroger Jr Hospital of Cook County, Chicago
- Decatur Memorial Hospital, Decatur
- Loyola University Medical Center, Maywood
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. okt. 2025 · NCT03418961Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.